These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 6259606
21. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF. Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [Abstract] [Full Text] [Related]
25. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. Burgess DS, Frei CR. J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664 [Abstract] [Full Text] [Related]
33. [Pefloxacin: clinical experience]. Bertrand A, Janbon F, Jourdan J, Jonquet O, Santoni A. Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133 [Abstract] [Full Text] [Related]
34. Cephalexin--a new oral cephalosporin: clinical evaluation in sixty-three patients. Fass RJ, Perkins RL, Saslaw S. Am J Med Sci; 1970 Mar; 259(3):187-200. PubMed ID: 5466475 [No Abstract] [Full Text] [Related]
35. Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Clumeck N, Van Laethem Y, Gordts B, Jaspar N, Butzler JP. Antimicrob Agents Chemother; 1983 Aug; 24(2):176-80. PubMed ID: 6357068 [Abstract] [Full Text] [Related]
36. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW. Clin Infect Dis; 2004 Sep 15; 39(6):812-8. PubMed ID: 15472813 [Abstract] [Full Text] [Related]
37. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units. Flournoy DJ, Reinert RL, Bell-Dixon C, Gentry CA. Am J Infect Control; 2000 Jun 15; 28(3):244-50. PubMed ID: 10840345 [Abstract] [Full Text] [Related]
38. [In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients (author's transl)]. Tancrede C, Mariel C, Chaigneau H, Eveno J. Nouv Presse Med; 1981 Feb 26; 10(8):545-7. PubMed ID: 6259589 [Abstract] [Full Text] [Related]
40. [Therapy of urinary tract infections with cefotaxime]. Horcicková M, Prát V, Hatala M, Liska M, Matousovic K. Cas Lek Cesk; 1985 Mar 15; 124(11):341-3. PubMed ID: 3978675 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]